FDA Approval: Sunvozertinib in EGFR Exon 20 NSCLC

Episode
299
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses EGFR exon 20 insertions and the recently approved targeted therapy for this subset of lung cancer: sunvozertinib. Dr. Mariam Alexander and Dr. James Chih-Hsin Yang join the conversation to help review the data and offer expertise and perspective on this new agent. 

Guest
Stephen Liu
Stephen Liu

MD

Chief of Hematology and Oncology, Associate Professor of Medicine
Georgetown University Hospital
Lombardi Comprehensive Cancer Center
James Chih-Hsin Yang
James Chih-Hsin Yang

MD, PhD

Distinguished Professor
Graduate Institute of Oncology, National Taiwan University
Director, National Taiwan University Cancer Center
Mariam Alexander
Mariam Alexander

MD

Thoracic Medical Oncologist, Assistant Professor of Medicine
Medical University of South Carolina, Hollings Cancer Center